Search results with tag "Qsymia"
Overview - Qsymia REMS
www.qsymiarems.comOverview The Food and Drug Administration (FDA) has required a Risk Evaluation and Mitigation Strategy (REMS) for Qsymia to ensure the benefits of Qsymia outweigh the increased risk of teratogenicity.
Risk of Birth Defects with Qsymia - Risk Evaluation …
www.qsymiarems.comRisk of Birth Defects with Qsymia (phentermine and topiramate extended-release) capsules CIV Please read the following important safety information about the use of Qsymia in females who
HIGHLIGHTS OF PRESCRIBING INFORMATION QSYMIA …
qsymia.com5.15 Kidney Stones 5.16 Oligohidrosis and Hyperthermia ... Determine the patient’s BMI. BMI is calculated by dividing weight (in kilograms) by height (in meters) ... based on height [inches (in) or centimeters (cm)] and weight [pounds (lb) or kilograms (kg)] is provided below. Table 1. BMI Conversion Chart . Weight (lb) 125 . 130 . 135 . 140 ...
Sample Appeal Letter [Name of Payer] [Address Re …
qsymia.comTitle: Microsoft Word - Sample Appeal Letter Qsymia 10 28 13 PRC approved USP Author: gloriad Created Date: 10/31/2013 9:57:11 AM
Qsymia Risk Evaluation and Mitigation Strategy ( …
www.qsymiarems.com© 2012-2014 VIVUS, Inc. All rights reserved. 08/2014 RE-03-013-01 Page 1 of 2 Qsymia® Risk Evaluation and Mitigation Strategy ( REMS) Pharmacy Enrollment Form - Independent Pharmacy